ターゲット次世代シーケンシングは、肺腺癌を持つ非喫煙者において非常に高い割合の分子ドライバ変異を明らかにする

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients2019 · 1,297 citations
2. 2Crystal structure of human KRAS G12C covalently bound to a phthalazine inhibitor2019 · 322 citations
3. 3TNM seventh edition: What's new, what's changed2010 · 474 citations
4. 4The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer2016 · 4,679 citations
5. 5Histology and Smoking Status Predict Survival of Patients with Advanced Non–Small-Cell Lung Cancer: Results of West Japan Oncology Group (WJOG) Study 3906L2013 · 47 citations